ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Advisors Approve Plans For New Grants In Imaging Research

July 10, 1998

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

June 27, 2003

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

January 17, 1992

In Brief: Robert Miller To Head International Affairs Office’ Pitot: No Basis for 20% Estimate

December 1, 1978

In Brief: Philadelphia Chromosome Discoverer Hungerford Dead; Oregon Recruits Scientists

November 12, 1993

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009